Zura Bio Ltd - ZURA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nimish Shah | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 9.9% | 9,816,384 | View |
| May 15, 2026 | SCHEDULE 13G/A | Great Point Partners, LLC | 4.44% | 4,215,930 | View |
| May 15, 2026 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 4.44% | 4,215,930 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 4.44% | 4,215,930 | View |
| May 12, 2026 | SCHEDULE 13G/A | Suvretta Capital Management, LLC | 9.9% | 9,524,263 | View |
| May 12, 2026 | SCHEDULE 13G/A | Averill Master Fund, Ltd. | 8.8% | 8,372,230 | View |
| May 12, 2026 | SCHEDULE 13G/A | Aaron Cowen | 9.9% | 9,524,263 | View |
| May 06, 2026 | SCHEDULE 13G/A | JPMORGAN CHASE & CO | 4.7% | 4,471,316 | View |
| Mar 02, 2026 | SCHEDULE 13D/A | — | 9.99% | 6,552,725 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Great Point Partners, LLC | 5.18% | 3,815,930 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 5.18% | 3,815,930 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 5.18% | 3,815,930 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | SUVRETTA CAPITAL MANAGEMENT, LLC | 8.6% | 5,567,001 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | AVERILL MASTER FUND, LTD | 7.7% | 4,995,444 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | AARON COWEN | 8.6% | 5,567,001 | View |
| Jan 27, 2026 | SCHEDULE 13D | — | 15.7% | — | View |
| Jan 02, 2026 | SCHEDULE 13G | Athanor Capital | 15.7% | 11,581,402 | View |
| Jan 02, 2026 | SCHEDULE 13G | UGS Capital LLC | 15.7% | 11,581,402 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.